Torsten Kessler

8PUBLICATIONS
67CO-AUTHORS
Solid tumoursEpidemiological methodsAdolescent healthMolecular targetsData quality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 20, 2026
Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS).

Stefan S Bielack, Dimosthenis Andreou, Daniel Baumhoer

|Oct 16, 2023
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.

Raphael Koch, Lianne Haveman, Ruth Ladenstein

|Apr 15, 2022
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.

Raphael Koch, Hans Gelderblom, Lianne Haveman

|Feb 15, 2022
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia.

Daniela V Wenge, Klaus Wethmar, Corinna A Klar

|Jul 02, 2021
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.

Andrew F Berdel, Christian Schwöppe, Caroline Brand

|Jun 11, 2020
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.

Christoph Schliemann, Mirjam Gerwing, Hauke Heinzow

Pageof 2

Frequent Collaborators

3 joint publications

Daniel Baumhoer

2 joint publications

Anna Raciborska

2 joint publications

Peter Hauser

2 joint publications

Lianne Haveman